1. Resistance to Anti-Angiogenic Therapy in Cancer—Alterations to Anti-VEGF Pathway
   Yoshiro Itatani et al, 2018, International Journal of Molecular Sciences CrossRef
2. HOXB9 inhibits proliferation in gastric carcinoma cells via suppression of phosphorylated-Akt and NF-κB-dependent Snail expression
   Li Zhang et al, 2019, Digestive and Liver Disease CrossRef
3. Identification of HOXB9 based on comprehensive bioinformatics analysis for predicting prognosis of head and neck squamous cell carcinoma
   Juanjuan Li et al, 2023, Medicine CrossRef
4. HOXA9 versus HOXB9; particular focus on their controversial role in tumor pathogenesis
   Ahmed Hjazi et al, 2024, Journal of Applied Genetics CrossRef
5. Homeobox B9 Promotes the Progression of Hepatocellular Carcinoma via TGF-β1/Smad and ERK1/2 Signaling Pathways
   Lizhi Bai et al, 2022, BioMed Research International CrossRef
6. Silencing of HOXB9 suppresses cellular proliferation, angiogenesis, migration and invasion of prostate cancer cells
   Hao Xu et al, 2020, Journal of Biosciences CrossRef
7. HOXB9 mediates resistance to chemotherapy and patient outcomes through the TGFβ pathway in pancreatic cancer
   Naokazu Chiba et al, 2022, Oncotarget CrossRef
8. Identification of HOXB9 to predict prognosis of endometrial cancer based on comprehensive bioinformatics analysis
   Yanhua Xu et al, 2023, European Journal of Medical Research CrossRef
9. The AMPK-HOXB9-KRAS axis regulates lung adenocarcinoma growth in response to cellular energy alterations
   Tianzhuo Wang et al, 2022, Cell Reports CrossRef
10. Identification and validation of a novel HOX-related classifier signature for predicting prognosis and immune microenvironment in pediatric gliomas
    Jiao Zhang et al, 2023, Frontiers in Cell and Developmental Biology CrossRef
11. HOX Genes Family and Cancer: A Novel Role for Homeobox B9 in the Resistance to Anti-Angiogenic Therapies
    Serena Contarelli et al, 2020, Cancers CrossRef